In a filing, Verona Pharma Plc ADR revealed its Chief Financial Officer Hahn Mark W unloaded Company’s shares for reported $1.91 million on May 29 ’25. In the deal valued at $9.33 per share,204,864 shares were sold. As a result of this transaction, Hahn Mark W now holds 12,678,992 shares worth roughly $1.03 billion.
Then, Hahn Mark W sold 162,704 shares, generating $1,513,294 in total proceeds. Upon selling the shares at $9.30, the Chief Financial Officer now owns 12,883,856 shares.
Before that, Hahn Mark W sold 32,432 shares. Verona Pharma Plc ADR shares valued at $308,983 were divested by the Chief Financial Officer at a price of $9.53 per share. As a result of the transaction, Hahn Mark W now holds 13,046,560 shares, worth roughly $1.06 billion.
TD Cowen initiated its Verona Pharma Plc ADR [VRNA] rating to a Buy in a research note published on April 28, 2025; the price target was $100. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late April with a ‘”an Overweight”‘ rating. ROTH MKM began covering VRNA with “Buy” recommendation on January 10, 2025. Wells Fargo started covering the stock on October 03, 2024. It rated VRNA as “an Overweight”.
Price Performance Review of VRNA
On Friday, Verona Pharma Plc ADR [NASDAQ:VRNA] saw its stock jump 4.79% to $81.20. Over the last five days, the stock has gained 11.71%. Verona Pharma Plc ADR shares have risen nearly 74.85% since the year began. Nevertheless, the stocks have risen 553.26% over the past one year. While a 52-week high of $77.98 was reached on 05/30/25, a 52-week low of $11.39 was recorded on 01/10/25. SMA at 50 days reached $65.99, while 200 days put it at $48.62.
Levels Of Support And Resistance For VRNA Stock
The 24-hour chart illustrates a support level at 78.97, which if violated will result in even more drops to 76.74. On the upside, there is a resistance level at 82.58. A further resistance level may holdings at 83.96. The Relative Strength Index (RSI) on the 14-day chart is 70.84, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.64, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 2.50%. Stochastics %K at 92.16% indicates the stock is a selling.
